Profile: Caplin Point Laboratories Ltd (CAPL.BO)

CAPL.BO on Bombay Stock Exchange

410.05INR
3:40pm IST
Price Change (% chg)

Rs15.05 (+3.81%)
Prev Close
Rs395.00
Open
Rs400.05
Day's High
Rs417.90
Day's Low
Rs400.05
Volume
1,959
Avg. Vol
8,674
52-wk High
Rs549.90
52-wk Low
Rs73.50

Search Stocks
Caplin Point Laboratories Limited operates in the pharmaceuticals formulations segment. The Company’s products include Aceclofenac, serratiopeptidase and paracetamol tablet, Pantoprazole injection 40mg, Tranexamic acid tab BP 500 milligram, Cycloserine tab 250 milligram, Warfarin sodium tab 5 milligram, 2 milligram,1 milligram, GANCICLOVIR SODIUM 500 milligram, OMEPRAZOLE INJECTION, ALUMINIUM HYDROXIDE Tablets, ARCET Syrup, ASPIRINA Tablets, CAPSULIDE Tablets, DICLOPAR Tablets, DIPIRONA Injection, MAYDIC Tablets, and MADAR Tablets. The Company main areas of focus are in the export of generic medicines to regions, such as Latin America, West Africa, South East Asia among others. The Company holds over 1300 product registrations in these markets.

Company Address

Caplin Point Laboratories Ltd

NARBAVI
No. 3, Lakshmanan Street, T. Nag
CHENNAI     600017
P: +9144.28156653
F: +9144.28154952

Search Stocks